{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:19:29Z","timestamp":1782235169274,"version":"3.54.5"},"reference-count":21,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1,25]]},"DOI":"10.1182\/blood.2023021307","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T21:01:04Z","timestamp":1700254864000},"page":"370-374","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":19,"title":["Characterization of reverse-engineered anti-PF4 stereotypic antibodies derived from serum of patients with VITT"],"prefix":"10.1182","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0114-5570","authenticated-orcid":false,"given":"Jing Jing","family":"Wang","sequence":"first","affiliation":[{"name":"1Department of Immunology, College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia"},{"name":"2Department of Immunology, SA Pathology, Flinders Medical Centre, Bedford Park, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijn","family":"van der Neut Kolfschoten","sequence":"additional","affiliation":[{"name":"3Janssen Vaccines & Prevention B.V., Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7363-6822","authenticated-orcid":false,"given":"Lucy","family":"Rutten","sequence":"additional","affiliation":[{"name":"3Janssen Vaccines & Prevention B.V., Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7613-1638","authenticated-orcid":false,"given":"Bridie","family":"Armour","sequence":"additional","affiliation":[{"name":"1Department of Immunology, College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia"},{"name":"2Department of Immunology, SA Pathology, Flinders Medical Centre, Bedford Park, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8623-5991","authenticated-orcid":false,"given":"Chee Wee","family":"Tan","sequence":"additional","affiliation":[{"name":"4Department of Medicine, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia"},{"name":"5Department of Hematology, SA Pathology, Adelaide, SA, Australia"},{"name":"6Department of Hematology, Royal Adelaide Hospital, Central Area Local Health Network, Adelaide, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0254-8099","authenticated-orcid":false,"given":"Tim","family":"Chataway","sequence":"additional","affiliation":[{"name":"7Flinders Proteomics Facility, College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinke","family":"Bos","sequence":"additional","affiliation":[{"name":"3Janssen Vaccines & Prevention B.V., Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemart","family":"Koornneef","sequence":"additional","affiliation":[{"name":"3Janssen Vaccines & Prevention B.V., Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravien","family":"Abeywickrema","sequence":"additional","affiliation":[{"name":"8Structural & Protein Sciences, Janssen Research and Development, Spring House, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1608-876X","authenticated-orcid":false,"given":"Rick","family":"Kapur","sequence":"additional","affiliation":[{"name":"9Sanquin Research, Department of Experimental Immunohematology, and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leendert","family":"Porcelijn","sequence":"additional","affiliation":[{"name":"10Department of Immunohematology Diagnostics, Sanquin Diagnostic Services, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midia","family":"Khalifa","sequence":"additional","affiliation":[{"name":"3Janssen Vaccines & Prevention B.V., Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ava","family":"Sadi","sequence":"additional","affiliation":[{"name":"3Janssen Vaccines & Prevention B.V., Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9388-1809","authenticated-orcid":false,"given":"Pascale","family":"Bouchier","sequence":"additional","affiliation":[{"name":"3Janssen Vaccines & Prevention B.V., Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Kourkouta","sequence":"additional","affiliation":[{"name":"3Janssen Vaccines & Prevention B.V., Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Perkasa","sequence":"additional","affiliation":[{"name":"3Janssen Vaccines & Prevention B.V., Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted","family":"Kwaks","sequence":"additional","affiliation":[{"name":"3Janssen Vaccines & Prevention B.V., Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2822-6231","authenticated-orcid":false,"given":"Roland","family":"Zahn","sequence":"additional","affiliation":[{"name":"3Janssen Vaccines & Prevention B.V., Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3786-6468","authenticated-orcid":false,"given":"Laura","family":"Solforosi","sequence":"additional","affiliation":[{"name":"3Janssen Vaccines & Prevention B.V., Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3232-8249","authenticated-orcid":false,"given":"Tom P.","family":"Gordon","sequence":"additional","affiliation":[{"name":"1Department of Immunology, College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia"},{"name":"2Department of Immunology, SA Pathology, Flinders Medical Centre, Bedford Park, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"22","key":"2024012516214173900_bib1","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"2024012516214173900_bib2","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"2024012516214173900_bib3","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"2024012516214173900_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev-med-043021-015237","article-title":"SARS-CoV-2 vaccination-induced thrombotic thrombocytopenia: a rare but serious immunologic complication","volume":"74","author":"Abrams","year":"2023","journal-title":"Annu Rev Med"},{"issue":"14","key":"2024012516214173900_bib5","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1182\/blood.2022017696","article-title":"Spotlight on vaccine-induced thrombosis and thrombocytopenia (VITT)","volume":"141","author":"Cines","year":"2023","journal-title":"Blood"},{"key":"2024012516214173900_bib6","doi-asserted-by":"crossref","first-page":"1040196","DOI":"10.3389\/fcvm.2022.1040196","article-title":"Vaccine-induced immune thrombotic thrombocytopenia: updates in pathobiology and diagnosis","volume":"9","author":"Jevtic","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"10","key":"2024012516214173900_bib7","doi-asserted-by":"crossref","first-page":"E363","DOI":"10.1002\/ajh.26659","article-title":"Human papilloma virus vaccine and VITT antibody induction","volume":"97","author":"Kanack","year":"2022","journal-title":"Am J Hematol"},{"issue":"3","key":"2024012516214173900_bib8","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/jth.15604","article-title":"Thrombosis and thrombocytopenia after HPV vaccination","volume":"20","author":"Johansen","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"2024012516214173900_bib9","doi-asserted-by":"crossref","first-page":"E223","DOI":"10.1002\/ajh.26542","article-title":"COVID-19 mRNA-1273\u00a0vaccine induces production of vaccine-induced immune thrombotic\u00a0thrombocytopenia antibodies","volume":"97","author":"Padmanabhan","year":"2022","journal-title":"Am J Hematol"},{"issue":"1","key":"2024012516214173900_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-0038-1651670","article-title":"Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases","volume":"73","author":"Amiral","year":"1995","journal-title":"Thromb Haemost"},{"issue":"1","key":"2024012516214173900_bib11","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.1038\/ncomms9277","article-title":"Atomic description of the immune complex involved in heparin-induced thrombocytopenia","volume":"6","author":"Cai","year":"2015","journal-title":"Nat Commun"},{"issue":"3","key":"2024012516214173900_bib12","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V72.3.925.bloodjournal723925","article-title":"Heparin-induced thrombocytopenia: laboratory studies","volume":"72","author":"Kelton","year":"1988","journal-title":"Blood"},{"issue":"7873","key":"2024012516214173900_bib13","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia","volume":"596","author":"Huynh","year":"2021","journal-title":"Nature"},{"issue":"1","key":"2024012516214173900_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1182\/blood.2021014588","article-title":"Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT","volume":"140","author":"Kanack","year":"2022","journal-title":"Blood"},{"issue":"2","key":"2024012516214173900_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.seminhematol.2022.02.005","article-title":"Platelet-activating anti-PF4 disorders: an overview","volume":"59","author":"Warkentin","year":"2022","journal-title":"Semin Hematol"},{"issue":"15","key":"2024012516214173900_bib16","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1182\/blood.2022016474","article-title":"Vaccine-induced immune thrombotic thrombocytopenia is mediated by a stereotyped clonotypic antibody","volume":"140","author":"Wang","year":"2022","journal-title":"Blood"},{"issue":"10","key":"2024012516214173900_bib17","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1016\/j.jtha.2023.06.026","article-title":"Antibodies against platelet factor 4 and the risk of cerebral venous sinus thrombosis in patients with vaccine-induced immune thrombotic thrombocytopenia","volume":"21","author":"Huynh","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2024012516214173900_bib18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1182\/bloodadvances.2022007336","article-title":"Characteristics of VITT antibodies\u00a0in patients vaccinated with Ad26.COV2.S","volume":"7","author":"Huynh","year":"2023","journal-title":"Blood Adv"},{"issue":"15","key":"2024012516214173900_bib19","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1182\/blood.2022017339","article-title":"Dangerous B-cell clones","volume":"140","author":"Greinacher","year":"2022","journal-title":"Blood"},{"issue":"23","key":"2024012516214173900_bib20","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1182\/blood.2021013839","article-title":"The interaction between anti-PF4 antibodies and anticoagulants in vaccine-induced thrombotic thrombocytopenia","volume":"139","author":"Singh","year":"2022","journal-title":"Blood"},{"issue":"1","key":"2024012516214173900_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0042-1759684","article-title":"COVID-19 vaccine-associated immune thrombosis and thrombocytopenia (VITT): diagnostic discrepancies and global implications","volume":"49","author":"Zidan","year":"2023","journal-title":"Semin Thromb Hemost"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/143\/4\/370\/2210302\/blood_bld-2023-021307-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/143\/4\/370\/2210302\/blood_bld-2023-021307-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T16:23:22Z","timestamp":1706199802000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/143\/4\/370\/498764\/Characterization-of-reverse-engineered-anti-PF4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,25]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,1,25]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2023021307","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,25]]}}}